The Directorate General of Health Services (DGHS) has recently issued revised COVID-19 treatment guidelines specifying the criteria for the use of certain drugs in treatment. These guidelines drastically cut down on the usage of several antibiotic drugs, steroids, excessive usage of Remdesivir, etc.
As per the DGHS guidelines, no medication is to be given to asymptomatic patients. It removed usage of popular drugs such as Ivermectin, Azithromycin, Doxycycline, Zinc, Favipiravir, and plasma therapy, etc for mild cases and retaining only the usage of antipyretics for fever and antitussive for cold symptoms.
The advisory states that Remdesivir should be provided by the hospitals and should not be procured from open retail markets.
The Government also advised physicians to exercise extreme caution with Emergency Use Authorisation (EUA) drug Remdesivir and Off-label drug Tocilizumab.
Remdesivir is to be used only in select moderate/ severe hospitalized Covid – 19 patients on supplemental oxygen as it is a reserve drug approved under Emergency Use Authorization. The guidelines further suggested not to use Remdesivir on mild Covid – 19 patients.
The document notes that steroids are harmful in asymptomatic and mild cases of COVID-19. Steroids should be taken by only hospitalized moderately severe and critically ill COVID-19 cases. Self-medication of steroids must be avoided.
Follow us on Twitter: https://twitter.com/PBNS_India
Like us on Facebook: https://www.facebook.com/PBNS.India
Follow us on Instagram: https://www.instagram.com/pbns.india/
Join us on Telegram: https://t.me/pbns_india
Follow us on Koo: https://www.kooapp.com/profile/pbns_i…